Roche announces positive Phase III study results for Tecentriq plus Cotellic and Zelboraf in people with previously untreated BRAF V600 mutation-positive advanced melanoma

David Linetsky
Point-of-Care Marketing

Bud Bilanich
Success Coach

Frank Burrell
Scientific Storytelling

Pat Purcell
Meeting Engagement

Amy Giles
Increasing Engagement

Liz Kane
Impactful Strategy

Daniel Sontupe
Market Access

Matthew Durham
Omnidynamic Marketing

Joey Cohen
Medication Adherence

Matt Turner
Patient Affordability

Stacey Gandler
Brand Nourishment

Suma Ramadas, PhD
Medical Affairs

Brenda Snow
Authentic Patient Voice

Paul Theisen
Patient Acquisition